MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
6.02
-0.15
-2.43%
After Hours: 6.02 0 0.00% 16:20 04/15 EDT
OPEN
6.17
PREV CLOSE
6.17
HIGH
6.27
LOW
5.87
VOLUME
1.39M
TURNOVER
0
52 WEEK HIGH
12.31
52 WEEK LOW
3.800
MARKET CAP
787.56M
P/E (TTM)
-67.0379
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CTKB last week (0408-0412)?
Weekly Report · 22h ago
Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?
NASDAQ · 6d ago
Weekly Report: what happened at CTKB last week (0401-0405)?
Weekly Report · 04/08 09:15
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Bio-Techne is a life science tools and services company focused on the development and sale of reagents and consumables for life science research. The company's focus on the stable and lucrative life science market has led to above-average growth and profitability compared to diagnostic companies. Bio- techne has exhibited strong financial performance, with high profit margins and low leverage. Healthcare is a strong sector for secular growth, but life science is more stable than diagnostics.
Seeking Alpha · 04/04 12:43
New Strong Buy Stocks for April 2nd
NASDAQ · 04/02 11:05
Weekly Report: what happened at CTKB last week (0325-0329)?
Weekly Report · 04/01 09:15
CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023
Cytek Biosciences reported earnings per share of 4 cents. The company reported revenue of $58.23 million. This was 2.92% better than the analyst estimate of $56.58 million for the quarter. The stock was down 2.7% in the after-hours session.
Investorplace · 03/27 15:53
Weekly Report: what happened at CTKB last week (0318-0322)?
Weekly Report · 03/25 09:14
More
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.